Centrus Energy (LEU) stock experienced a significant 24-hour surge of 5.21% on Wednesday, building upon its impressive pre-market gains. The nuclear fuel and services provider's stock price rally was fueled by the release of its exceptional second-quarter 2025 financial results and positive developments in its contracts with the Department of Energy.
The company reported adjusted earnings per share of $1.59, substantially beating the analyst consensus estimate of $0.82 by 93.43%. Revenue for the quarter came in at $154.50 million, surpassing expectations of $125.49 million by 23.11%. Despite representing a year-over-year decrease, these figures demonstrate Centrus's ability to outperform market expectations in challenging conditions. The company also saw improvements in its gross profit margin, which expanded to 34.9% from 19.3% in the same period last year, and its net profit margin, which increased to 18.7% from 16.2% year-over-year.
Adding to the positive sentiment, Centrus announced the successful completion of Phase 2 of its HALEU Operation Contract, delivering 900 kilograms of high-assay low-enriched uranium (HALEU) to the Department of Energy. Furthermore, the Department exercised a portion of Phase 3 of the contract, valued at approximately $110 million, extending through June 30, 2026. This development signals continued confidence in Centrus's capabilities and provides a strong foundation for future growth in the nuclear energy sector. With a reported backlog of $3.6 billion as of June 30, 2025, extending to 2040, Centrus Energy appears well-positioned for sustained growth in the evolving nuclear energy industry.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.